A detailed history of Xtx Topco LTD transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 22,695 shares of IBRX stock, worth $89,191. This represents 0.01% of its overall portfolio holdings.

Number of Shares
22,695
Previous 36,427 37.7%
Holding current value
$89,191
Previous $195,000 26.67%
% of portfolio
0.01%
Previous 0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$4.82 - $9.15 $66,188 - $125,647
-13,732 Reduced 37.7%
22,695 $143,000
Q1 2024

May 13, 2024

BUY
$3.23 - $6.17 $117,659 - $224,754
36,427 New
36,427 $195,000
Q4 2022

Feb 14, 2023

BUY
$4.35 - $6.77 $112,891 - $175,695
25,952 Added 205.37%
38,589 $195,000
Q3 2022

Nov 14, 2022

BUY
$3.65 - $6.43 $46,125 - $81,255
12,637 New
12,637 $63,000
Q1 2022

May 13, 2022

SELL
$5.05 - $7.53 $96,752 - $144,267
-19,159 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$5.67 - $10.18 $108,631 - $195,038
19,159 New
19,159 $116,000

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $1.57B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.